Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment.

OBJECTIVES To determine if there were any differences in antiretroviral treatment (ART) use across the three eastern states of Australia, New South Wales (NSW), Victoria and Queensland, during the period 1997 to 2006. METHODS We used data from a clinic-based cohort, the Australian HIV Observational Database (AHOD), to determine the proportion of HIV-infected patients on ART in selected clinics in each state and the proportion of treated patients with an undetectable viral load. Data from the national Highly Specialised Drugs program and AHOD were used to estimate total numbers of individuals on ART and the proportion of individuals living with HIV on ART nationally and by state. Data from the HIV Futures Survey and the Gay Community Periodic Survey were used to determine the proportion of community-based men who have sex with men on ART. The proportion of patients with primary HIV infection (PHI) who commenced ART within 1 year of diagnosis was obtained from the Acute Infection and Early Disease Research Program (AIEDRP) CORE01 protocol and Primary HIV and Early Disease Research: Australian Cohort (PHAEDRA) cohorts. RESULTS We estimated that the numbers of individuals on ART increased from 3181 to 4553 in NSW, 1309 to 1926 in Victoria and 809 to 1615 in Queensland between 2000 and 2006. However, these numbers may reflect a lower proportion of individuals living with HIV on ART in NSW compared with the other states (37% compared with 49 and 55% in 2000). We found similar proportions of HIV-positive men who have sex with men participants were on ART in all three states over the study period in the clinic-based AHOD cohort (81-92%) and two large, community-based surveys in Australia (69-85% and 49-83%). Similar proportions of treated patients had an undetectable viral load across the three states, with a consistently increasing trend over time observed in all states. We found that more PHI patients commenced treatment in the first year following HIV diagnosis in NSW compared with Victoria; however, the sample size was very small. CONCLUSIONS For the most part, patterns of ART use were similar across NSW, Victoria and Queensland using a range of available data from cohort studies, community surveys and national prescription databases in Australia. However, there may be a lower proportion of individuals living with HIV on ART in NSW compared with the other states, and there is some indication of a more aggressive treatment approach with PHI patients in NSW compared with Victoria.

[1]  J. Kaldor,et al.  Characteristics of HIV diagnoses in Australia, 1993-2006. , 2008, Sexual health.

[2]  J. Kaldor,et al.  HIV diagnoses in Australia: diverging epidemics within a low‐prevalence country , 2007, The Medical journal of Australia.

[3]  M. Pitts,et al.  State of the (positive) nation: findings from the fourth national Australian HIV futures survey , 2007, International journal of STD & AIDS.

[4]  B. Martin,et al.  Centralising the blame game , 2007 .

[5]  J. Hocking,et al.  Comparisons of trends in antiretroviral use and HIV notification rates between three Australian States , 2007, Australian and New Zealand journal of public health.

[6]  Lei Wang,et al.  A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. , 2006, The Journal of infectious diseases.

[7]  M. Pitts,et al.  Health and wellbeing of HIV-positive Australians: findings from the third national HIV Futures Survey , 2005, International journal of STD & AIDS.

[8]  D. Cooper,et al.  Combined Analysis of Two-Year Follow-Up from Two Open-Label Randomized Trials Comparing Efficacy of Three Nucleoside Reverse Transcriptase Inhibitor Backbones for Previously Untreated HIV-1 Infection: OzCombo 1 and 2 , 2003, HIV clinical trials.

[9]  C. Moore,et al.  Rates of combination antiretroviral treatment change in Australia, 1997–2000 , 2002 .

[10]  Australian Hiv Observational Database Rates of combination antiretroviral treatment change in Australia, 1997-2000. , 2002, HIV medicine.

[11]  R. D. de Visser,et al.  More cautious, more optimistic: Australian people living with HIV/AIDS, 1997–1999 , 2001, International journal of STD & AIDS.

[12]  D. Cooper,et al.  A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study , 2000, AIDS.

[13]  T. Quinn,et al.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.

[14]  D. Podzamczer,et al.  A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study. , 1999, AIDS.